L‐ornithine L‐aspartate vs lactulose
All‐cause mortality · people with cirrhosis who had minimal or overt hepatic encephalopathy or who were at risk for developing hepatic encephalopathy;…
It is very uncertain whether L‐ornithine L‐aspartate changes mortality compared with lactulose (very low certainty).
1 finding from 1 review
- L‐ornithine L‐aspartate for prevention and treatment of hepatic encephalopathy in people with cirrhosis 2018 · Cochrane Headline outcomes onlyRR 0.68 [0.11, 4.17]4 studies · 175 participantsVery low